China Resources Boya Bio-pharmaceutical Group Co., Ltd.

  • Market Cap: Large Cap
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: CNE100001FF1
CNY
23.69
-3.98 (-14.38%)
  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-recommendationAnnual Results
Results Snapshot
Figures in Million
Consolidate Annual Results
Dec'24
Dec'23
Dec'22
Dec'21
Dec'20
Dec'19
Dec'18
Net Sales
1,716.42
2,631.91
2,736.78
2,630.54
2,493.48
2,887.70
2,428.45
Other Operating Income
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Total Operating income
1,716.42
2,631.91
2,736.78
2,630.54
2,493.48
2,887.70
2,428.45
Raw Material Cost
670.93
1,311.51
1,310.15
1,202.18
1,127.59
1,162.95
953.28
Purchase of Finished goods
0.00
0.00
0.00
0.00
0.00
0.00
0.00
(Increase) / Decrease In Stocks
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Employee Cost
191.87
220.55
236.02
202.78
177.36
195.18
0.00
Power Cost
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Manufacturing Expenses
1.09
0.80
0.92
10.90
21.87
31.32
24.24
Selling and Distribution Expenses
560.36
725.84
873.95
950.48
1,005.86
1,113.40
879.00
Other Expenses
-13.04
-15.82
-19.18
-18.92
-16.10
-13.79
1.79
Total Expenditure (Excl Depreciation)
1,293.85
2,100.46
2,229.27
2,177.11
2,171.69
2,364.99
1,874.39
Operating Profit (PBDIT) excl Other Income
422.59999999999997
531.4
507.5
453.40000000000003
321.8
522.7
554.0999999999999
Other Income
74.61
67.29
73.37
71.30
20.63
34.45
46.82
Operating Profit (PBDIT)
613.93
709.41
692.19
636.85
436.55
649.44
667.91
Interest
1.09
0.80
0.92
10.90
21.87
31.32
24.24
Exceptional Items
-18.21
-240.99
-48.54
-69.86
-0.27
-0.19
-0.08
Gross Profit (PBDT)
1,045.49
1,320.40
1,426.63
1,428.36
1,365.89
1,724.75
1,475.17
Depreciation
116.91
113.91
110.72
112.98
94.60
93.94
67.03
Profit Before Tax
477.71
353.71
532.00
443.12
319.81
523.99
576.56
Tax
81.19
105.56
86.51
84.84
52.87
77.92
87.16
Provisions and contingencies
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Profit After Tax
396.99
237.47
432.20
344.53
260.06
426.15
469.17
Extraordinary Items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Prior Period Expenses
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Other Adjustments
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Net Profit
396.99
237.47
432.20
344.53
260.06
426.15
469.17
Share in Profit of Associates
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Minority Interest
-0.46
10.68
13.29
13.75
15.20
15.98
15.90
Other related items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Consolidated Net Profit
396.53
248.15
445.49
358.28
275.26
442.12
485.08
Equity Capital
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Face Value
1.0
1.0
1.0
1.0
1.0
1.0
1.0
Reserves
7,487.15
7,319.75
7,185.63
6,829.07
4,107.90
3,911.73
3,704.66
Earnings per share (EPS)
0.79
0.47
0.86
0.79
0.61
1.0
1.11
Diluted Earnings per share
0.79
0.47
0.86
0.79
0.61
1.0
1.11
Operating Profit Margin (Excl OI)
24.61%
20.07%
18.57%
17.2%
12.89%
18.04%
22.82%
Gross Profit Margin
34.64%
17.77%
23.48%
21.14%
16.62%
21.4%
26.5%
PAT Margin
23.13%
9.02%
15.79%
13.1%
10.43%
14.76%
19.32%
Public Share Holdings (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Pledged Promotor Holding (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Annual Analysis Highlights
stock-summary

Net Sales

YoY Growth in year ended Dec 2024 is -34.78% vs -3.83% in Dec 2023

stock-summary

Consolidate Net Profit

YoY Growth in year ended Dec 2024 is 59.81% vs -44.31% in Dec 2023

stock-summary

Operating Profit (PBDIT) excl Other Income

YoY Growth in year ended Dec 2024 is -16.01% vs 3.77% in Dec 2023

stock-summary

Interest

YoY Growth in year ended Dec 2024 is 37.50% vs -11.11% in Dec 2023

stock-summary

Operating Profit Margin (Excl OI)

YoY Growth in year ended Dec 2024 has improved from Dec 2023

Compare Annual Results Of China Resources Boya Bio-pharmaceutical Group Co., Ltd. With
Markets Mojo
Figures in Million
Consolidate Annual Results
Markets Mojo
Markets Mojo
Change(CNY)
Change(%)
Net Sales
1,716.42
0
1,716.42
Other Operating Income
0.00
0.00
0.00
Total Operating income
1,716.42
0
1,716.42
Raw Material Cost
670.93
0
670.93
Purchase of Finished goods
0
0
0.00
(Increase) / Decrease In Stocks
0
0
0.00
Employee Cost
191.87
0
191.87
Power Cost
0
0
0.00
Manufacturing Expenses
1.09
0
1.09
Selling and Distribution Expenses
560.36
0
560.36
Other Expenses
-13.04
0.00
-13.04
Total Expenditure (Excl Depreciation)
1,293.85
0
1,293.85
Operating Profit (PBDIT) excl Other Income
422.57
0.00
422.57
Other Income
74.61
0
74.61
Operating Profit (PBDIT)
613.93
0
613.93
Interest
1.09
0
1.09
Exceptional Items
-18.21
0
-18.21
Gross Profit (PBDT)
1,045.49
0
1,045.49
Depreciation
116.91
0
116.91
Profit Before Tax
477.71
0
477.71
Tax
81.19
0
81.19
Provisions and contingencies
0
0
0.00
Profit After Tax
396.99
0
396.99
Extraordinary Items
0.00
0
0.00
Prior Period Expenses
0
0
0.00
Other Adjustments
0
0
0.00
Net Profit
396.99
0
396.99
Share in Profit of Associates
0
0
0.00
Minority Interest
-0.46
0
-0.46
Other related items
0.00
0.00
0.00
Consolidated Net Profit
396.53
0
396.53
Equity Capital
0
0
0.00
Face Value
1.00
0
0.00
Reserves
7,487.15
0
7,487.15
Earnings per share (EPS)
0.79
0
0.79
Diluted Earnings per share
0.79
0
0.79
Operating Profit Margin (Excl OI)
24.61%
0%
0.00
24.61%
Gross Profit Margin
34.64%
0%
0.00
34.64%
PAT Margin
23.13%
0%
0.00
23.13%
Public Share Holdings (%)
0%
0%
0.00
0.00%
Pledged Promotor Holding (%)
0%
0%
0.00
0.00%
Annual - Net Sales
Net Sales 171.64 Million
in Dec 2024

Figures in Million
stock-summary

YoY Growth in year ended Dec 2024 is -34.78% vs -3.83% in Dec 2023

Annual - Consolidate Net Profit
Consolidate Net Profit 39.65 Million
in Dec 2024

Figures in Million
stock-summary

YoY Growth in year ended Dec 2024 is 59.81% vs -44.31% in Dec 2023

Annual - Operating Profit (PBDIT)
Operating Profit (PBDIT) 53.93 Million
in Dec 2024

Figures in Million
stock-summary

YoY Growth in year ended Dec 2024 is -16.01% vs 3.77% in Dec 2023

Annual - Interest
Interest 0.11 Million
in Dec 2024

Figures in Million
stock-summary

YoY Growth in year ended Dec 2024 is 37.50% vs -11.11% in Dec 2023

Annual - Operating Profit Margin (Excl OI)
Operating Profit Margin (Excl OI) 24.61%
in Dec 2024

Figures in %
stock-summary

YoY Growth in year ended Dec 2024 has improved from Dec 2023